Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLINT trial of metformin for cardiovascular event prevention in non-diabetic hyperglycaemia
2012-005570-56Phase 4Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in cardiac morbidity (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Time to first confirmed major cardiovascular event. Started Nov 2013; status: terminated.
02
Drugs
metformin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2012-005570-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005570-56.